Dexur specializes in providing advanced healthcare solutions to tackle the critical issues of patient readmissions and mortalities. With our access to Out of Hospital Data, as an approved purchaser of CMS Medicare claims data, we offer unparalleled insights that extend beyond the confines of hospital walls, allowing us to address the intricate dynamics between readmissions and mortalities.

Dexur Reamissions and Mortality Resources:

• The Difference Between the 10th & 90th Performance Percentiles of CMS Readmission and Mortality Measures is Very Small

• Nearly 60% of Deaths for CMS Mortality Measures Happen Outside the Index Stay

• Nearly 30% of Readmissions are to a Different Hospital From the Index Stay

• 20-40% of Deaths for CMS Pneumonia, HF, AMI and COPD 30 Day Mortality Measures have an Hospice Interaction

• Browse CMS Readmissions and Mortality Predictions and Guidance 1-3 Years in Advance by State

• Search for Your Hospital’s CMS Star Rating Predictions and Guidance by Going to Dexur.com and Searching for Your Hospital. Here is an example of Yale New Haven Hospital.

• Dexur and Harvard Medical School Researchers have published several papers on Readmissions and Mortality Outcomes

Tackling Readmissions & Mortalities Together:

At Dexur, we have observed a potential inverse correlation between readmissions and mortalities when not monitored simultaneously. Our comprehensive approach ensures that both aspects are addressed concurrently, providing a balanced strategy to optimize patient outcomes and enhance healthcare quality.

Impact on Quality Measures:

Understanding the implications is vital - Readmissions influence the Hospital Readmissions Reduction Program (HRRP) & CMS Star Rating scores, while Mortality rates affect the CMS Hospital Value-Based Purchasing (VBP) Program and CMS Star Ratings. Our insights and solutions are designed to help healthcare providers improve these essential quality measures, thereby contributing to better patient care and hospital performance.

AI-Based Risk Factor Identification:

Leverage Dexur’s advanced AI technology to identify patients at the highest risk for readmissions and mortality. For instance, we can precisely calculate the odds ratios for readmissions and mortality for COPD patients with diabetes at your Hospital. This enables healthcare providers to implement targeted interventions and provide personalized care to those who need it most.

Unrivaled Insights with Out of Hospital Data:

Dexur stands out by providing a more holistic view of patient health through access to Out-of - Hospital Data, which many hospitals lack. This comprehensive data access enables us to develop more effective strategies and interventions to reduce readmissions and mortalities.

Why Choose Dexur?

• Exclusive Data Access: Utilize insights from our exclusive access to CMS Medicare claims data, offering a broader view of patient health beyond hospital stays.

• Balanced Approach: Address readmissions and mortalities concurrently to prevent potential inverse correlations and ensure optimal patient outcomes.

• Impact on Quality Measures: Improve essential hospital quality measures such as HRRP, VBP, and CMS Star Ratings with our tailored solutions.

• Advanced Risk Identification: Employ AI-based tools to identify and address high-risk patients, optimizing personalized care and intervention strategies.